Skip to main content

HPV Prevention





Human Papilloma Virus (HPV) is a major leading cause of Human Cancer. Through this series we would like to highlight the quality and the breadth of the research being carried out on the Control and Prevention of HPV and HPV related disease. This series aims to bring together a diverse range of HPV related specialities featuring research that has as ultimate goal insights into HPV related disease reduction. Articles can have a wide range of topics such as those of natural history studies, impact of screening interventions or impact of HPV vaccines will be most welcome.

Relevant research papers published in Infectious Agents and Cancer will be added to the series, with commentary to explain their significance, or put them in context for no specialist readers.

The section includes:

  • News on HPV research, highlight of events or articles that deserve particular attention for their relevance or controversy
  • A major research article on HPV with priority for community trials or demonstration projects of preventive strategies
  • A collection of relevant articles that relate to HPV disease reduction.

This collection of articles is a retrospective collection, has not been sponsored and the articles have undergone the journal's standard peer-review process.

Edited by:
Franco M Buonaguro, MD, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" , Italy
Maria Lina Tornesello, MD, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" , Italy

View all collections published in Infectious Agents and Cancer.


  1. The rationale behind current worldwide human papilloma virus (HPV) vaccination programs starts from two basic premises, 1) that HPV vaccines will prevent cervical cancers and save lives and, 2) have no risk of...

    Authors: Lucija Tomljenovic, Judy Wilyman, Eva Vanamee, Toni Bark and Christopher A Shaw
    Citation: Infectious Agents and Cancer 2013 8:6
  2. Information on human papillomavirus (HPV) type distribution is necessary to evaluate the potential impact of current and future HPV vaccines. We estimated the relative contribution (RC) to invasive cervical ca...

    Authors: Beatriz Serrano, Laia Alemany, Sara Tous, Laia Bruni, Gary M Clifford, Thomas Weiss, Francesc Xavier Bosch and Silvia de Sanjosé
    Citation: Infectious Agents and Cancer 2012 7:38
  3. Human Papilloma Virus (HPV) is a major leading cause of Human Cancer. Through the HPV Prevention series we would like to highlight the quality and the breadth of the research being carried out on the Control a...

    Authors: Silvia de Sanjosé
    Citation: Infectious Agents and Cancer 2012 7:37
  4. HPV infection in the genital tract is common in young sexually active individuals, the majority of whom clear the infection without overt clinical disease. However most of those who develop benign lesions even...

    Authors: Margaret Stanley
    Citation: Infectious Agents and Cancer 2010 5:19
  5. Virtually all cases of cervical cancer are caused by persistent infections with a restricted set of human papillomaviruses (HPV). Some HPV types, like HPV16 and HPV18, are clear and powerful carcinogens. Howev...

    Authors: Mark Schiffman, Gary Clifford and Franco M Buonaguro
    Citation: Infectious Agents and Cancer 2009 4:8
  6. We describe type-specific progression, regression and persistence of incident human papillomavirus (HPV)-6-11-16 and -18 infections, along with type distribution in cervical intra-epithelial neoplasia (CIN) le...

    Authors: Ralph P Insinga, Erik J Dasbach, Elamin H Elbasha, Kai-Li Liaw and Eliav Barr
    Citation: Infectious Agents and Cancer 2007 2:15
  7. The distribution of human papillomaviruses (HPVs) varies greatly across populations and HPV surveys have been performed in different geographical regions in order to apply appropriate vaccine strategies. Littl...

    Authors: Maria Lina Tornesello, Maria Luisa Duraturo, Luigi Buonaguro, Gabriele Vallefuoco, Roberto Piccoli, Stefano Palmieri and Franco M Buonaguro
    Citation: Infectious Agents and Cancer 2007 2:1